ABO-Incompatible Transplant: When Blood Types Do Not Match

ABO-incompatible transplant means the donor and recipient blood groups do not match in the usual way, but transplantation may still be possible in selected cases. The main challenge is that the recipient may have antibodies against the donor blood type, which can injure the transplanted organ if not controlled.
Key Takeaways
- ABO-incompatible transplant means the donor and recipient blood groups do not match in the usual way, but transplantation may still be possible in selected cases.
- The main challenge is that the recipient may have antibodies against the donor blood type, which can injure the transplanted organ if not controlled.
- Preparation often includes antibody testing, antibody-removal treatments, and medicines that reduce the immune response.
- This approach is most often discussed in living donor kidney transplantation and, in selected situations, liver transplantation.
- Long-term success depends on careful patient selection, an experienced transplant team, medication adherence and regular follow-up.
An ABO-incompatible transplant is a carefully planned organ transplant performed when the donor and recipient have different blood types. With modern desensitization methods, close monitoring and experienced transplant teams, selected patients may have another path to transplantation when a fully blood-type-compatible donor is not available.
Overview
An ABO-incompatible transplant is an organ transplant performed when the donor and recipient have different ABO blood groups that would traditionally be considered incompatible. Blood types are commonly known as A, B, AB and O. These blood groups are determined by markers, called antigens, on cells. The immune system naturally makes antibodies against the ABO antigens a person does not have.
In a standard transplant, doctors try to match the donor and recipient in several ways, including blood type compatibility, tissue matching and overall medical suitability. When ABO blood types do not match, the recipient’s antibodies can recognize the donor organ as foreign. Without preparation, this may cause antibody-mediated rejection, a form of rejection in which antibodies attack the blood vessels of the transplanted organ.
Modern transplant medicine has made ABO-incompatible transplantation possible for selected patients, especially in living donor kidney transplant programs and some liver transplant settings. The process usually involves lowering or removing harmful antibodies before surgery and using medicines to control the immune response. It is a specialized approach that requires detailed planning, laboratory monitoring and close follow-up after transplant.
Why Blood Type Compatibility Matters

The ABO blood group system is one of the most important compatibility checks in transplantation. For example, a person with blood type A usually has antibodies against type B, while a person with type B usually has antibodies against type A. A person with type O usually has antibodies against both A and B, and a person with type AB typically has no naturally occurring anti-A or anti-B antibodies.
In a blood-type-compatible transplant, the recipient’s immune system is less likely to immediately react to the donor organ because the ABO antigens are acceptable. In an ABO-incompatible transplant, the recipient may have circulating antibodies that bind to the donor organ’s blood vessels. This can trigger inflammation, clotting and organ injury if not prevented.
Compatibility is not limited to ABO blood type. Doctors also assess tissue matching, donor-specific antibodies, crossmatch results, organ quality, the urgency of transplantation and the patient’s overall health. ABO incompatibility is therefore one part of a larger transplant evaluation. A patient may be ABO-incompatible but still suitable for transplant if the risks can be carefully reduced.
Who May Be Considered for ABO-Incompatible Transplant

ABO-incompatible transplant is usually considered when the potential benefit of proceeding with a known donor outweighs the risks of waiting for a compatible donor. In kidney transplantation, this may apply to patients with a healthy and willing living donor whose blood type does not match. It may also be considered when waiting times are long or when other matching options are limited.
For liver transplantation, the situation is different because liver grafts may respond differently to blood group antibodies than kidney grafts. ABO-incompatible liver transplantation may be considered in selected circumstances, often when transplant need is urgent and alternatives are limited. The exact approach depends on the patient’s age, diagnosis, urgency, antibody levels and the center’s experience.
Patients are assessed individually. The transplant team reviews medical history, previous transfusions, pregnancies, earlier transplants, infections, heart and lung health, kidney or liver function, and the strength of ABO antibodies. Some patients are better served by waiting for a compatible donor, entering a paired kidney exchange program, or considering other treatment options.
- Possible candidates may include patients with a medically suitable living donor but incompatible blood type.
- Patients with very high antibody levels may need more preparation or may not be suitable for this approach.
- People with active infection, uncontrolled medical problems or inability to follow immunosuppressive treatment may need stabilization before transplant.
Preparation and Desensitization
Preparation for an ABO-incompatible transplant is often called desensitization. The goal is to reduce the amount of anti-A or anti-B antibodies in the recipient’s blood and to lower the chance that the immune system will attack the transplanted organ. This process begins before surgery and continues through the early recovery period, when the risk of rejection is closely monitored.
Common desensitization methods include antibody-removal treatments such as plasmapheresis or immunoadsorption. These procedures filter the blood to remove antibodies. The patient may also receive replacement fluids or immune proteins, depending on the protocol. Blood tests are performed repeatedly to measure antibody levels and decide whether additional sessions are needed.
Medicines are another key part of preparation. Transplant specialists may use immunosuppressive drugs before and after surgery, sometimes including treatments that reduce certain immune cells involved in antibody production. The exact medications, timing and intensity vary by patient and transplant center. Patients should never adjust or stop transplant medicines without direct medical advice, because missed doses can increase the risk of rejection.
The Transplant Procedure and Hospital Care
The surgery itself is generally similar to a compatible transplant of the same organ, but the preparation and monitoring are more intensive. For a kidney transplant, the donor kidney is placed in the recipient’s lower abdomen and connected to blood vessels and the bladder. For a liver transplant, the diseased liver is removed and replaced with a donor liver or part of a donor liver, depending on the type of transplant.
During the hospital stay, the team monitors organ function, antibody levels, fluid balance, blood counts, infection markers and medication levels. Kidney transplant patients are followed with urine output and blood tests such as creatinine. Liver transplant patients are followed with liver enzymes, bilirubin, clotting tests and imaging when needed. These tests help the team detect early changes before symptoms develop.
Some patients may need additional antibody-removal sessions after surgery if antibody levels rise. Others may only need routine post-transplant care. Recovery plans include pain control, gradual movement, nutrition support, wound care and education on medications. Before discharge, patients and families receive instructions about warning signs, follow-up appointments, hygiene, food safety and how to take immunosuppressive medicines correctly.
Benefits, Risks and Long-Term Outlook
The main potential benefit of ABO-incompatible transplant is access to transplantation when a compatible donor is not available. For some kidney patients, receiving a living donor transplant may reduce time on dialysis and allow surgery to be scheduled when both donor and recipient are medically ready. For selected liver patients, it may provide an option when the need for a donor organ is urgent.
The risks include antibody-mediated rejection, infection, bleeding related to antibody-removal procedures, side effects of immunosuppressive medicines and complications related to surgery. Because desensitization reduces parts of the immune response, infection prevention and early treatment are important. Patients are taught to report fever, wound changes, urinary symptoms, jaundice, unusual fatigue or any sudden change in health.
Long-term outlook depends on many factors: the transplanted organ, antibody levels, other immune risks, donor and recipient health, surgical factors and adherence to follow-up care. Many patients do well with careful management, but ABO-incompatible transplant is not considered routine for every patient. A transplant team should explain the expected benefits and risks in the context of the patient’s individual condition.
Alternatives, Self-Care and When to Seek Medical Advice
ABO-incompatible transplant is one option among several. For kidney patients, alternatives may include waiting for a deceased donor, finding another compatible living donor, or participating in a paired kidney exchange program, where incompatible donor-recipient pairs are matched with other pairs. For some patients, these options may reduce the need for desensitization. The best choice depends on medical suitability, donor availability, urgency and local transplant resources.
Self-care after any transplant is essential. Patients should take medicines exactly as prescribed, attend all follow-up visits, keep vaccination and infection-prevention plans up to date with their doctor, and maintain a healthy lifestyle. A balanced diet, safe food handling, blood pressure control, diabetes management, avoiding tobacco and discussing all new medicines or supplements with the transplant team can support long-term organ health.
Patients should contact their transplant team promptly if they develop fever, increasing pain, swelling, redness or drainage from the wound, reduced urine output after kidney transplant, yellowing of the skin or eyes after liver transplant, persistent vomiting or diarrhea, shortness of breath, chest pain, or missed doses of immunosuppressive medication. Acibadem International’s multidisciplinary transplant specialists and JCI-accredited hospitals diagnose and treat transplant patients, including international patients, with individualized evaluation and follow-up planning.
Frequently asked questions
What does ABO-incompatible transplant mean?
It means the donor and recipient have ABO blood types that do not match in the usual compatible way. Because the recipient may have antibodies against the donor blood type, special preparation is needed to reduce the risk of rejection.
Is ABO-incompatible transplant safe?
For carefully selected patients, ABO-incompatible transplant can be performed with structured preparation and close monitoring. It does carry additional risks compared with a fully compatible transplant, so the decision should be made after a detailed discussion with an experienced transplant team.
Which organs can be transplanted across blood types?
ABO-incompatible transplantation is most commonly discussed for living donor kidney transplantation. It may also be considered in selected liver transplant situations. The approach, risks and eligibility criteria differ by organ and by patient.
What is desensitization before transplant?
Desensitization is treatment used to lower harmful antibodies before transplantation. It may include antibody-removal procedures and immunosuppressive medicines. The aim is to help the transplanted organ function without being attacked by the recipient’s ABO antibodies.
Can antibody levels rise again after surgery?
Yes, antibody levels can rise after transplant, especially in the early period. This is why frequent blood tests and follow-up visits are important. If levels rise or organ function changes, the transplant team may adjust treatment.
Is a paired kidney exchange better than ABO-incompatible kidney transplant?
Paired kidney exchange can be an excellent option for some incompatible donor-recipient pairs because it may allow a compatible transplant without intensive desensitization. However, it depends on whether a suitable exchange match is available. The transplant team can compare both options based on the patient’s antibody levels, waiting time and medical condition.
References
- World Health Organization
- European Society for Organ Transplantation
- American Society of Transplantation
- The Transplantation Society
- Kidney Disease: Improving Global Outcomes
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
Explore treatments in Turkey — costs, top hospitals & a free quote
JCI-accredited · board-certified surgeons · reply within 24h
Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.









